Literature DB >> 9024869

Trypanosoma cruzi: the major cysteinyl proteinase (cruzipain) is a relevant immunogen of parasite acidic antigens (FIII).

D Laderach1, F Cerban, C Motran, E Vottero de Cima, S Gea.   

Abstract

This study examined the immune responses induced by cruzipain, a well-characterized T. cruzi antigen, to determine whether it is a relevant immunogen among the parasite acidic antigens (FIII), for which some biological properties have been studied previously. Humoral and cellular immune responses were investigated in BALB/C mice after immunization with cruzipain or FIII. Skin tests revealed immediate type-hypersensitivity (ITH) and delayed-type hypersensitivity (DTH) reactions to cruzipain in both groups of immunized mice. IgG1 and IgE isotypes against cruzipain were detected by ELISA in both groups and immunoblot studies showed that these antibodies recognized a major protein band of 50 kDa, cruzipain. The antigen-specific proliferative responses of spleen lymphocytes from both groups of immunized mice were also increased. Immunization with cruzipain of FIII antigen significantly enhanced the percentage survival of mice challenged with 10(3) trypomastigotes. The results revealed high cross-reactivity between cruzipain and FIII, suggesting the cruzipain is a relevant immunogen among the parasite acidic antigens.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9024869     DOI: 10.1016/s0020-7519(96)00099-9

Source DB:  PubMed          Journal:  Int J Parasitol        ISSN: 0020-7519            Impact factor:   3.981


  6 in total

1.  Trypanosoma cruzi infection induces a massive extrafollicular and follicular splenic B-cell response which is a high source of non-parasite-specific antibodies.

Authors:  Daniela A Bermejo; María C Amezcua Vesely; Mahmood Khan; Eva V Acosta Rodríguez; Carolina L Montes; Maria C Merino; Kai Michael Toellner; Elodie Mohr; Dale Taylor; Adam F Cunningham; Adriana Gruppi
Journal:  Immunology       Date:  2010-09-28       Impact factor: 7.397

2.  Trypanosoma cruzi antigen immunization induces a higher B cell survival in BALB/c mice, a susceptible strain, compared to C57BL/6 B lymphocytes, a resistant strain to cardiac autoimmunity.

Authors:  Andrea Pellegrini; Eugenio Antonio Carrera-Silva; Alfredo Arocena; Roxana Carolina Cano; Maria Pilar Aoki; Susana Gea
Journal:  Med Microbiol Immunol       Date:  2011-03-24       Impact factor: 3.402

3.  BAFF mediates splenic B cell response and antibody production in experimental Chagas disease.

Authors:  Daniela A Bermejo; María C Amezcua-Vesely; Carolina L Montes; María C Merino; Ricardo C Gehrau; Hugo Cejas; Eva V Acosta-Rodríguez; Adriana Gruppi
Journal:  PLoS Negl Trop Dis       Date:  2010-05-04

4.  Prophylactic efficacy of TcVac2 against Trypanosoma cruzi in mice.

Authors:  Shivali Gupta; Nisha Jain Garg
Journal:  PLoS Negl Trop Dis       Date:  2010-08-10

5.  The increase in mannose receptor recycling favors arginase induction and Trypanosoma cruzi survival in macrophages.

Authors:  Vanina V Garrido; Laura R Dulgerian; Cinthia C Stempin; Fabio M Cerbán
Journal:  Int J Biol Sci       Date:  2011-10-25       Impact factor: 6.580

6.  Heterologous Chimeric Construct Comprising a Modified Bacterial Superantigen and a Cruzipain Domain Confers Protection Against Trypanosoma cruzi Infection.

Authors:  María Belén Antonoglou; Andrés Sánchez Alberti; Daniela María Redolfi; Augusto Ernesto Bivona; María Julieta Fernández Lynch; Sofía Noli Truant; María Belén Sarratea; Laura Valeria Iannantuono López; Emilio Luis Malchiodi; Marisa Mariel Fernández
Journal:  Front Immunol       Date:  2020-06-30       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.